cyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate

C133H256N22O16 — CID 161098362

IUPACcyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate
SMILESCC(C)C(=O)NC1CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CN(C)C)CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CC(C)N1CCC(C)(NC(=O)OC2CCOC2)CC1.CC(C)N1CCC(C)(NC(=O)OCC2CC2)CC1.CC(C)N1CCC(CN(C)C)(NC(=O)CC2CC2)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC2CC2)CC1.CC(C)N1CCC(NC(=O)OC2CCC2)CC1.CCOC(=O)NC1(C)CCN(C(C)C)CC1
InChIInChI=1S/C18H33N3O2.C18H35N3O2.C16H31N3O.C16H33N3O.C14H26N2O3.C14H26N2O2.C13H24N2O2.C12H24N2O2.C12H24N2O/c1-15(2)21-7-5-18(6-8-21,14-20-9-11-23-12-10-20)19-17(22)13-16-3-4-16;1-15(2)13-17(22)19-18(14-20-9-11-23-12-10-20)5-7-21(8-6-18)16(3)4;1-13(2)19-9-7-16(8-10-19,12-18(3)4)17-15(20)11-14-5-6-14;1-13(2)11-15(20)17-16(12-18(5)6)7-9-19(10-8-16)14(3)4;1-11(2)16-7-5-14(3,6-8-16)15-13(17)19-12-4-9-18-10-12;1-11(2)16-8-6-14(3,7-9-16)15-13(17)18-10-12-4-5-12;1-10(2)15-8-6-11(7-9-15)14-13(16)17-12-4-3-5-12;1-5-16-11(15)13-12(4)6-8-14(9-7-12)10(2)3;1-9(2)12(15)13-11-5-7-14(8-6-11)10(3)4/h15-16H,3-14H2,1-2H3,(H,19,22);15-16H,5-14H2,1-4H3,(H,19,22);13-14H,5-12H2,1-4H3,(H,17,20);13-14H,7-12H2,1-6H3,(H,17,20);11-12H,4-10H2,1-3H3,(H,15,17);11-12H,4-10H2,1-3H3,(H,15,17);10-12H,3-9H2,1-2H3,(H,14,16);10H,5-9H2,1-4H3,(H,13,15);9-11H,5-8H2,1-4H3,(H,13,15)
InChIKeyUICFXOWIOATJHJ-UHFFFAOYSA-N
MW2419.65 g/mol
LogP16.78
Rot. Bonds40

About cyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate

cyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate (PubChem CID 161098362) has the molecular formula C133H256N22O16 and a molecular weight of 2419.65 g/mol. Its IUPAC name is cyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate.

Molecular Properties

Compound Namecyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate
PubChem CID161098362
Molecular FormulaC133H256N22O16
Molecular Weight2419.65 g/mol
Exact Mass2417.99
IUPAC Namecyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate
SMILESCC(C)C(=O)NC1CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CN(C)C)CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CC(C)N1CCC(C)(NC(=O)OC2CCOC2)CC1.CC(C)N1CCC(C)(NC(=O)OCC2CC2)CC1.CC(C)N1CCC(CN(C)C)(NC(=O)CC2CC2)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC2CC2)CC1.CC(C)N1CCC(NC(=O)OC2CCC2)CC1.CCOC(=O)NC1(C)CCN(C(C)C)CC1
InChIInChI=1S/C18H33N3O2.C18H35N3O2.C16H31N3O.C16H33N3O.C14H26N2O3.C14H26N2O2.C13H24N2O2.C12H24N2O2.C12H24N2O/c1-15(2)21-7-5-18(6-8-21,14-20-9-11-23-12-10-20)19-17(22)13-16-3-4-16;1-15(2)13-17(22)19-18(14-20-9-11-23-12-10-20)5-7-21(8-6-18)16(3)4;1-13(2)19-9-7-16(8-10-19,12-18(3)4)17-15(20)11-14-5-6-14;1-13(2)11-15(20)17-16(12-18(5)6)7-9-19(10-8-16)14(3)4;1-11(2)16-7-5-14(3,6-8-16)15-13(17)19-12-4-9-18-10-12;1-11(2)16-8-6-14(3,7-9-16)15-13(17)18-10-12-4-5-12;1-10(2)15-8-6-11(7-9-15)14-13(16)17-12-4-3-5-12;1-5-16-11(15)13-12(4)6-8-14(9-7-12)10(2)3;1-9(2)12(15)13-11-5-7-14(8-6-11)10(3)4/h15-16H,3-14H2,1-2H3,(H,19,22);15-16H,5-14H2,1-4H3,(H,19,22);13-14H,5-12H2,1-4H3,(H,17,20);13-14H,7-12H2,1-6H3,(H,17,20);11-12H,4-10H2,1-3H3,(H,15,17);11-12H,4-10H2,1-3H3,(H,15,17);10-12H,3-9H2,1-2H3,(H,14,16);10H,5-9H2,1-4H3,(H,13,15);9-11H,5-8H2,1-4H3,(H,13,15)
InChIKeyUICFXOWIOATJHJ-UHFFFAOYSA-N
XLogP16.78
TPSA368.63 Ų
H-Bond Donors9
H-Bond Acceptors29
Rotatable Bonds40
Heavy Atoms171
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002419.65
LogP ≤ 516.78
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1029

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Analyze cyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of cyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate?
The IUPAC name of cyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate (CID 161098362) is cyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate.
What is the SMILES notation for cyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate?
The canonical SMILES for cyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate is CC(C)C(=O)NC1CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CN(C)C)CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CC(C)N1CCC(C)(NC(=O)OC2CCOC2)CC1.CC(C)N1CCC(C)(NC(=O)OCC2CC2)CC1.CC(C)N1CCC(CN(C)C)(NC(=O)CC2CC2)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC2CC2)CC1.CC(C)N1CCC(NC(=O)OC2CCC2)CC1.CCOC(=O)NC1(C)CCN(C(C)C)CC1.
What is the InChIKey of cyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate?
The InChIKey is UICFXOWIOATJHJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H33N3O2.C18H35N3O2.C16H31N3O.C16H33N3O.C14H26N2O3.C14H26N2O2.C13H24N2O2.C12H24N2O2.C12H24N2O/c1-15(2)21-7-5-18(6-8-21,14-20-9-11-23-12-10-20)19-17(22)13-16-3-4-16;1-15(2)13-17(22)19-18(14-20-9-11-23-12-10-20)5-7-21(8-6-18)16(3)4;1-13(2)19-9-7-16(8-10-19,12-18(3)4)17-15(20)11-14-5-6-14;1-13(2)11-15(20)17-16(12-18(5)6)7-9-19(10-8-16)14(3)4;1-11(2)16-7-5-14(3,6-8-16)15-13(17)19-12-4-9-18-10-12;1-11(2)16-8-6-14(3,7-9-16)15-13(17)18-10-12-4-5-12;1-10(2)15-8-6-11(7-9-15)14-13(16)17-12-4-3-5-12;1-5-16-11(15)13-12(4)6-8-14(9-7-12)10(2)3;1-9(2)12(15)13-11-5-7-14(8-6-11)10(3)4/h15-16H,3-14H2,1-2H3,(H,19,22);15-16H,5-14H2,1-4H3,(H,19,22);13-14H,5-12H2,1-4H3,(H,17,20);13-14H,7-12H2,1-6H3,(H,17,20);11-12H,4-10H2,1-3H3,(H,15,17);11-12H,4-10H2,1-3H3,(H,15,17);10-12H,3-9H2,1-2H3,(H,14,16);10H,5-9H2,1-4H3,(H,13,15);9-11H,5-8H2,1-4H3,(H,13,15).
What are the key properties of cyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate?
cyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate has a molecular weight of 2419.65 g/mol, XLogP of 16.78, 40 rotatable bonds, 9 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for cyclobutyl N-(1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]acetamide;cyclopropylmethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;2-cyclopropyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]acetamide;N-[4-[(dimethylamino)methyl]-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;ethyl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate;3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;2-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide;oxolan-3-yl N-(4-methyl-1-propan-2-ylpiperidin-4-yl)carbamate is sourced from PubChem (CID 161098362), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).